← Back to Search

Intervention for Chronic Obstructive Pulmonary Disease

N/A
Waitlist Available
Led By Monica Rabanal, MSc, BSN
Research Sponsored by Fisher and Paykel Healthcare
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up through study completion, an average of 6 months
Awards & highlights

Study Summary

"This trial is testing to make sure that the Airvo 3 device with a respiratory rate algorithm made by Fisher & Paykel Healthcare is accurate for monitoring a person's breathing rate continuously."

Who is the study for?
This trial is for healthy individuals and those with Chronic Obstructive Pulmonary Disease (COPD) to test the accuracy of a respiratory rate monitoring device called Airvo 3. Specific eligibility criteria are not provided, but typically participants would need to meet certain health standards.Check my eligibility
What is being tested?
The study aims to validate the performance of the Airvo 3, which is a device designed by Fisher & Paykel Healthcare that monitors breathing rates using an algorithm. The focus is on ensuring its accuracy in continuous respiratory rate measurement.See study design
What are the potential side effects?
Since this trial involves non-invasive monitoring with a device, side effects are expected to be minimal or nonexistent. However, any discomfort or issues related to wearing the device will be monitored.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~through study completion, an average of 6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and through study completion, an average of 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Secondary outcome measures
Respiratory rate

Trial Design

1Treatment groups
Experimental Treatment
Group I: InterventionExperimental Treatment1 Intervention
This arm will receive the study intervention

Find a Location

Who is running the clinical trial?

Fisher and Paykel HealthcareLead Sponsor
120 Previous Clinical Trials
9,888 Total Patients Enrolled
Monica Rabanal, MSc, BSNPrincipal InvestigatorElement Boulder

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any available positions for participants in this research study?

"As per clinicaltrials.gov, the trial status indicates that patient recruitment is not ongoing at present. The study was initially listed on April 1st, 2024 and last updated on March 24th, 2024. Although this specific trial is no longer accepting participants, there are currently a substantial number of 1115 alternative trials actively enrolling patients."

Answered by AI
Recent research and studies
clinicaltrials.govStudy
Airvo 3 Respiratory Rate Validation Study
2024. "Airvo 3 Respiratory Rate Validation Study". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06329609.
~40 spots leftby Oct 2024
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top